CR Bard (BCR)
Q1 2012 Earnings Call
April 24, 2012 5:00 pm ET
Timothy M. Ring - Chairman, Chief Executive Officer and Chairman of Executive Committee
John H. Weiland - President, Chief Operating Officer and Director
Todd C. Schermerhorn - Chief Financial Officer and Senior Vice President
John A. DeFord - Senior Vice President of Science Technology & Clinical Affairs
Jonathan J. Palmer - Credit Agricole Securities (USA) Inc., Research Division
Michael Matson - Mizuho Securities USA Inc., Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
Frederick A. Wise - Leerink Swann LLC, Research Division
Matthew J. Dodds - Citigroup Inc, Research Division
Jason Wittes - Caris & Company, Inc., Research Division
David R. Lewis - Morgan Stanley, Research Division
Topher Orr - Goldman Sachs Group Inc., Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
Matthew O'Brien - William Blair & Company L.L.C., Research Division
Lennox Ketner - BofA Merrill Lynch, Research Division
Daniel Sollof - Barclays Capital, Research Division
Joshua T. Jennings - Cowen and Company, LLC, Research Division
Anthony Petrone - Jefferies & Company, Inc., Research Division
Robert M. Goldman - CL King & Associates, Inc.
Ladies and gentlemen, thank you for standing by. Welcome to the C. R. Bard, Inc. First Quarter 2012 Earnings Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded and will be available for future on-demand replay through Bard's website. Today's presentation will be hosted by Timothy M. Ring, Chairman and Chief Executive Officer; along with Jay H. Weiland, President and Chief Operating Officer; Todd C. Schermerhorn, Senior Vice President and Chief Financial Officer; and John A. DeFord, Senior Vice President, Science Technology and Clinical Affairs. Also in attendance today is Todd W. Garner, Vice President, Investor Relations.
Today, Bard's management will discuss some forward-looking statements, the accuracy of which are necessarily subject to risks and uncertainties. Please refer to the cautionary statement regarding forward-looking information and the information under the caption Risk Factors, each in Bard's 2011 10-K, including disclosures of factors that could cause actual results to differ materially from those expressed or implied.